Oral Session 2-12D Ph+ALL

[OS2-12D-1] Prognostic impact of BCR-ABL gene mutation on transplant outcomes in patients with Ph-positive ALL

Takayoshi Tachibana¹, Yuho Najima², Yu Akahoshi³, Shigeki Hirabayashi⁴, Kaito Harada⁵, Kazuteru Ohashi², Naoyuki Uchida⁶, Takahiro Fukuda⁷, Masashi Sawa⁸, Masao Ogata⁹, Junji Tanaka¹⁰, Tatsuo Ichinohe¹¹, Yoshiko Atsuta¹², Shinichi Kako³ (1.Dep. of Hematology, Kanagawa Cancer Center, Yokohama, Japan, 2.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Saitama Medical Center, Jichi Medical University, Saitama, Japan, 4.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 5.Department of Hematology and Oncology, Tokai University, Isehara, Japan, 6.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 7.National Cancer Center Hospital, Tokyo, Japan, 8.Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan, 9.Department of Hematology, Oita University Hospital, Oita, Japan, 10.Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan, 11.Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan, 12.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)